[EN] NOVEL CANNABINOID RECEPTOR LIGANDS, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, AND PROCESS FOR THEIR PREPARATION<br/>[FR] NOUVEAUX LIGANDS DU RÉCEPTEUR CANNOBINOÏDE, COMPOSITIONS PHARMACEUTIQUES LES CONTENANT ET LEUR PROCÉDÉ DE PRÉPARATION
申请人:GLENMARK PHARMACEUTICALS SA
公开号:WO2009053799A1
公开(公告)日:2009-04-30
The present invention relates to compounds of f formula (I) as cannabinoid receptor modulators, in particular cannabinoid 1 (CB1) or cannabinoid 2 (CB2 ) receptor modulators, and uses thereof f or treating diseases, conditions and/or disorders modulated by a cannabinoid receptor ( such as pain, neurodegenrative disorders, eating disorders, weight loss or control, and obesity).
本发明涉及公式(I)的化合物作为大麻素受体调节剂,特别是大麻素1(CB1)或大麻素2(CB2)受体调节剂,以及它们的用途用于治疗由大麻素受体调节的疾病、症状和/或障碍(如疼痛、神经退行性疾病、进食障碍、体重减轻或控制以及肥胖症)。